In contrast, 5-amino-1mq is often administered orally, which may result in more variable absorption and bioavailability depending on individual patient factors
Preliminary findings from these studies suggest a tolerable oral dosage of approximately 100mg/kg in mice [1]
Keep reading to learn more about the benefits and side effects of AOD peptide therapy
CLINICAL STUDY
By inhibiting NNMT, 5-Amino 1MQ becomes the catalyst for halting fat cell growth, rekindling fat breakdown, and emerging as a potential anti-obesity ally
Of note, the relative abundance of the Parasutterella genus, which was significantly enriched in both the vehicle- and 5A-1MQ-treated animals transitioned from WD to LD compared to both the WD and LD control groups, was observed to be significantly correlated (either positively or negatively) with 30 EWAT metabolites, both with and without outliers included